Return to search

Optimisation of the Montanide ISA 206 B oil adjuvanted foot and mouth disease vaccine containing the southern African territories (SAT) serotypes.

M. Tech. Veterinary Technology. / Aims of this study were to: determine the suitable buffers and optimal concentrations of these buffers, to be used in the ISA 206 B oil-based vaccine formulations that will ensure pH levels of &#x2265%x; 7.0; consistent emulsion type and particle sizes following a storage period of at least 24 months at 4 C ; determine the effects of temperature on the stability of the vaccine formulation during storage ; determine the optimal buffer antigen ratio in the water phase of the ISA 206 B oil-adjuvanted FMD vaccine containing SAT serotypes ; determine the effects of saponin (Q-Vac trade mark) on the buffering capacity during storage, in the ISA 206 B oil-adjuvanted FMD vaccine containing the SAT serotypes; and determine the shelf life of this improved (stabilised) oil vaccine. Previous research by the ARC scientists has shown that the immunity elicited by the ISA 206 oil adjuvanted vaccines could persist up to 50 weeks post vaccination in cattle (Cloete et al., 2008; Hunter, 1996). However, they did not show if this immunity was protective or not. Although it is known within the FMD field that sometimes immunity levels do not always translate into protection against an infection, if protection can be shown - even after vaccination using a stored vaccines - achievement of the above mentioned objectives could enable a once-a-year vaccination regimen in the control zone of RSA. Moreover, this once-a-year vaccination regimen could also substantially reduce the logistical costs involved during vaccination campaigns, compared to the current biannual vaccination regimen. Once the shelf life of the vaccine has been established, the vaccine could also be registered as a stock remedy under the Fertilisers, Farm Feed, Agricultural Remedies and Stock Remedies Act, 36 of 1947, administered by DAFF. The registration of this vaccine could in turn enable the RSA to supply the vaccine to neighbouring South African Development Community (SADC) countries and the rest of African countries where the SAT serotypes occur.

Identiferoai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:tut/oai:encore.tut.ac.za:d1001101
Date January 2013
CreatorsPeta, Faith Rosemary Masekgala.
Source SetsSouth African National ETD Portal
LanguageEnglish
Detected LanguageEnglish
TypeText
FormatPDF

Page generated in 0.0018 seconds